KC Business Journal: UMKC, Children’s Mercy add research tool to ID genetic diseases
The University of Missouri-Kansas City and Children’s Mercy jointly acquired a “state of the art device” on Monday. The new mass spectrometer can measure and analyze proteins quickly for a number of uses.
“We welcome opportunities to synergize with UMKC in support of Children's Mercy’s mission,” said Tom Curran, chief scientific officer and executive director of the Children’s Mercy Children’s Research Institute. “This high-tech instrumentation installed at UMKC will be particularly useful to our outstanding Clinical Pharmacology and Genomic Medicine research programs. “
The Center for Pediatric Genomic Medicine is the first genome center inside a children’s hospital focusing on genome sequencing and analysis for inherited children’s diseases. The new mass spectrometer will be a key component of this research, thanks to its high level of protein analysis capabilities.